Literature DB >> 22357897

Using radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections.

Chung Y Kong1, Janie M Lee, Pamela M McMahon, Kathryn P Lowry, Zehra B Omer, Jonathan D Eisenberg, Pari V Pandharipande, G Scott Gazelle.   

Abstract

PURPOSE: To evaluate the effect of incorporating radiation risk into microsimulation (first-order Monte Carlo) models for breast and lung cancer screening to illustrate effects of including radiation risk on patient outcome projections.
MATERIALS AND METHODS: All data used in this study were derived from publicly available or deidentified human subject data. Institutional review board approval was not required. The challenges of incorporating radiation risk into simulation models are illustrated with two cancer screening models (Breast Cancer Model and Lung Cancer Policy Model) adapted to include radiation exposure effects from mammography and chest computed tomography (CT), respectively. The primary outcome projected by the breast model was life expectancy (LE) for BRCA1 mutation carriers. Digital mammographic screening beginning at ages 25, 30, 35, and 40 years was evaluated in the context of screenings with false-positive results and radiation exposure effects. The primary outcome of the lung model was lung cancer-specific mortality reduction due to annual screening, comparing two diagnostic CT protocols for lung nodule evaluation. The Metropolis-Hastings algorithm was used to estimate the mean values of the results with 95% uncertainty intervals (UIs).
RESULTS: Without radiation exposure effects, the breast model indicated that annual digital mammography starting at age 25 years maximized LE (72.03 years; 95% UI: 72.01 years, 72.05 years) and had the highest number of screenings with false-positive results (2.0 per woman). When radiation effects were included, annual digital mammography beginning at age 30 years maximized LE (71.90 years; 95% UI: 71.87 years, 71.94 years) with a lower number of screenings with false-positive results (1.4 per woman). For annual chest CT screening of 50-year-old females with no follow-up for nodules smaller than 4 mm in diameter, the lung model predicted lung cancer-specific mortality reduction of 21.50% (95% UI: 20.90%, 22.10%) without radiation risk and 17.75% (95% UI: 16.97%, 18.41%) with radiation risk.
CONCLUSION: Because including radiation exposure risk can influence long-term projections from simulation models, it is important to include these risks when conducting modeling-based assessments of diagnostic imaging. © RSNA, 2012.

Entities:  

Mesh:

Year:  2012        PMID: 22357897      PMCID: PMC3285223          DOI: 10.1148/radiol.11110352

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  28 in total

Review 1.  Managing radiation use in medical imaging: a multifaceted challenge.

Authors:  Hedvig Hricak; David J Brenner; S James Adelstein; Donald P Frush; Eric J Hall; Roger W Howell; Cynthia H McCollough; Fred A Mettler; Mark S Pearce; Orhan H Suleiman; James H Thrall; Louis K Wagner
Journal:  Radiology       Date:  2010-12-16       Impact factor: 11.105

2.  Estimated risks of radiation-induced fatal cancer from pediatric CT.

Authors:  D Brenner; C Elliston; E Hall; W Berdon
Journal:  AJR Am J Roentgenol       Date:  2001-02       Impact factor: 3.959

3.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

Authors:  A Antoniou; P D P Pharoah; S Narod; H A Risch; J E Eyfjord; J L Hopper; N Loman; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; O-P Kallioniemi; D Thompson; C Evans; J Peto; F Lalloo; D G Evans; D F Easton
Journal:  Am J Hum Genet       Date:  2003-04-03       Impact factor: 11.025

4.  Radiation and smoking effects on lung cancer incidence among atomic bomb survivors.

Authors:  Kyoji Furukawa; Dale L Preston; Stefan Lönn; Sachiyo Funamoto; Shuji Yonehara; Takeshi Matsuo; Hiromi Egawa; Shoji Tokuoka; Kotaro Ozasa; Fumiyoshi Kasagi; Kazunori Kodama; Kiyohiko Mabuchi
Journal:  Radiat Res       Date:  2010-07       Impact factor: 2.841

5.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers.

Authors:  Stefan Diederich; Dag Wormanns; Michael Semik; Michael Thomas; Horst Lenzen; Nikolaus Roos; Walter Heindel
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

7.  Screening for lung cancer with low-dose spiral computed tomography.

Authors:  Stephen J Swensen; James R Jett; Jeff A Sloan; David E Midthun; Thomas E Hartman; Anne-Marie Sykes; Gregory L Aughenbaugh; Frank E Zink; Shauna L Hillman; Gayle R Noetzel; Randolph S Marks; Amy C Clayton; Peter C Pairolero
Journal:  Am J Respir Crit Care Med       Date:  2002-02-15       Impact factor: 21.405

8.  Cost-effectiveness of computed tomography screening for lung cancer in the United States.

Authors:  Pamela M McMahon; Chung Yin Kong; Colleen Bouzan; Milton C Weinstein; Lauren E Cipriano; Angela C Tramontano; Bruce E Johnson; Jane C Weeks; G Scott Gazelle
Journal:  J Thorac Oncol       Date:  2011-11       Impact factor: 15.609

9.  Radiation effects on breast cancer risk: a pooled analysis of eight cohorts.

Authors:  Dale L Preston; Anders Mattsson; Erik Holmberg; Roy Shore; Nancy G Hildreth; John D Boice
Journal:  Radiat Res       Date:  2002-08       Impact factor: 2.841

10.  Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.

Authors:  David J Brenner; Richard Doll; Dudley T Goodhead; Eric J Hall; Charles E Land; John B Little; Jay H Lubin; Dale L Preston; R Julian Preston; Jerome S Puskin; Elaine Ron; Rainer K Sachs; Jonathan M Samet; Richard B Setlow; Marco Zaider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

View more
  6 in total

1.  Prioritizing examination-centered over patient-centered dose reduction: a hazard of institutional "benchmarking".

Authors:  Jonathan D Eisenberg; Michael E Gilmore; Mannudeep K Kalra; Chung Yin Kong; Pari V Pandharipande
Journal:  AJR Am J Roentgenol       Date:  2014-05       Impact factor: 3.959

Review 2.  Imaging-based screening: understanding the controversies.

Authors:  Diana L Lam; Pari V Pandharipande; Janie M Lee; Constance D Lehman; Christoph I Lee
Journal:  AJR Am J Roentgenol       Date:  2014-11       Impact factor: 3.959

3.  Comparative effectiveness and child health.

Authors:  Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

4.  Patients with testicular cancer undergoing CT surveillance demonstrate a pitfall of radiation-induced cancer risk estimates: the timing paradox.

Authors:  Pari V Pandharipande; Jonathan D Eisenberg; Richard J Lee; Michael E Gilmore; Ekin A Turan; Sarabjeet Singh; Mannudeep K Kalra; Bob Liu; Chung Yin Kong; G Scott Gazelle
Journal:  Radiology       Date:  2012-12-18       Impact factor: 11.105

5.  From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF).

Authors:  S Couraud; A B Cortot; L Greillier; V Gounant; B Mennecier; N Girard; B Besse; L Brouchet; O Castelnau; P Frappé; G R Ferretti; L Guittet; A Khalil; P Lefebure; F Laurent; S Liebart; O Molinier; E Quoix; M-P Revel; B Stach; P-J Souquet; P Thomas; J Trédaniel; E Lemarié; G Zalcman; F Barlési; B Milleron
Journal:  Ann Oncol       Date:  2012-11-07       Impact factor: 32.976

6.  Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.

Authors:  Peter J Mazzone; Gerard A Silvestri; Lesley H Souter; Tanner J Caverly; Jeffrey P Kanne; Hormuzd A Katki; Renda Soylemez Wiener; Frank C Detterbeck
Journal:  Chest       Date:  2021-07-13       Impact factor: 9.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.